The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: analysis of the CREDENCE trial

File(s)

The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics_analysis of the CREDENCE trial.pdf (182.35 KB)

Accepted version

Show more

Author(s)

de Zeeuw, D

Arnott, C

Li, J-W

Cannon, CP

Neuen, BL

more

Type

Conference Paper

Date Issued

2020-09-01

Date Acceptance

2020-09-01

Citation

DIABETOLOGIA, 2020, 63 (SUPPL 1), pp.S61-S62

URI

http://hdl.handle.net/10044/1/84303

ISSN

0012-186X

Publisher

SPRINGER

Start Page

S61

End Page

S62

Journal / Book Title

DIABETOLOGIA

Volume

63

Issue

SUPPL 1

Copyright Statement

© 2020 The Author(s)

Identifier

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000565776600123&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Source

56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)

Subjects

Science & Technology

Life Sciences & Biomedicine

Endocrinology & Metabolism

Publication Status

Published

Start Date

2020-09-21

Finish Date

2020-09-25

Coverage Spatial

ELECTR NETWORK

Date Publish Online

2020-09